Name

Chapper Healthcare

Legal name

Philip Chapper & Company Limited

Website

https://chapperhealthcare.com

Company type

Private

Founded year

1975

Operating status

Operating

Headcount range

11–50 employees

Ownership category

akta.pro rank

Product category

Pharmaceutical Wholesale and Distribution

NAICS

Drugs and Druggists' Sundries Merchant Wholesalers (42421), Drugs and Druggists' Sundries Merchant Wholesalers (424210), Warehousing and Storage (493)

SIC

Wholesale-Drugs, Proprietaries & Druggists' Sundries (5122)

akta.pro primary industry

Vaccines & Temperature-Sensitive Medical Deliveries (2–8°C, CRT) (TLAAAIAF)

akta.pro secondary industries

Controlled Substances & High-Security Medical Courier (Chain-of-Custody) (TLAAAIAG), Transplant & Organ / Tissue Transport (Time-Critical) (TLAAAIAH)

Keywords

• Pharmaceutical wholesale distribution
• Unlicensed medicines supply
• Temperature-controlled logistics
• Clinical trials supply
• Named patient supply

Headquarters

HQ city

Watford

HQ country

United Kingdom

HQ region

Europe

Offices5 records

Markets served

GTM type

B2B

Offering type

Services

Cost components

Personnel, Operations, Technology or R&D, Marketing or Sales, Infrastructure, Supply Chain

Revenue model

1. Pharmaceutical Wholesale Distribution: Revenue from importing and exporting licensed and unlicensed pharmaceuticals, supplying medicines to NHS hospitals, private hospitals, wholesalers, and healthcare providers globally.
2. Third-Party Logistics Services: Providing warehousing, storage, distribution, and temperature-controlled logistics services to pharmaceutical manufacturers, including customs clearance and batch release.
3. Named Patient/Managed Access Supply: Supply of unlicensed medicines for specific patients, including orphan drugs and rare disease therapies through named patient programmes.
4. Clinical Trials Supply: Sourcing and supplying comparator drugs, reference products for clinical trials with batch-specific delivery worldwide.

Pricing tiers

Go-to-market motion3 records

Distribution channels5 records

Marketing channels7 records

Core offering

Chapper Healthcare is a global pharmaceutical wholesaler and distributor that imports and exports licensed and unlicensed medicines, provides temperature-controlled logistics with cold-chain capabilities, supplies clinical trials, and distributes specialty and orphan drugs to NHS and private hospitals across the UK and Ireland. It also offers third-party logistics (3PL), warehousing, customs clearance, batch release, and managed access/named patient supply services to pharmaceutical manufacturers worldwide, operating from MHRA and HPRA-licensed facilities.

Product overview

CHAPPER healthcare is a global pharmaceutical wholesaler, distributor, and services provider operating since 1975. The company functions as a single integrated platform offering multiple connected services: unlicensed medicines supply, temperature-controlled logistics, clinical trials supply, managed access/named patient programs, UK/Ireland hospital distribution, and strategic manufacturer partnerships. The EUROPACCESS pan-European alliance extends their reach across 30+ healthcare systems. Key distributed products include Aridol®/Osmohale® for asthma management and ASCORBIC ACID PASCOE for injection/infusion. Services are delivered through MHRA and HPRA-licensed facilities in the UK, Ireland, Germany, and USA, with temperature-controlled capabilities spanning ambient (15-25°C), refrigerated (2-8°C), and frozen storage.

Differentiator

Problem solved

Functional benefit

Products and services

• Unlicensed Medicines and Market Shortages Supply Import and export of unlicensed and non-registered medicines, enabling pharmacies and clinicians worldwide to supply patients with urgently needed medicines, including rapid-response supply during market shortages and emergency medicine requests.
• Temperature-Controlled Logistics and 3PL Services Complete range of temperature-controlled logistical solutions including cold storage at 2–8°C, frozen storage, and ambient storage at 15–25°C, with validated PCM shippers, USB temperature data loggers, GMDP-compliant warehousing, customs clearance, batch release, re-packing, and blind shipment services for pharmaceutical manufacturers globally.
• Clinical Trials Supply Sourcing and supply of comparator drugs and reference products for clinical trials, with dedicated account team support and worldwide logistics delivery on a batch-specific basis.
• Managed Access and Named Patient Supply Supply of medicines on a named-patient or managed access basis, including orphan drugs and medicines not yet licensed for specific disease areas, for individual patients with documented clinical need.
• UK and Ireland Hospital Distribution Distribution of hospital products to NHS and private hospitals across the UK and Ireland, including exclusive distribution services for selected manufacturers and temperature-compliant delivery.
• Pharmaceutical Distribution Services Global pharmaceutical distribution services for clients across Europe, Asia, Africa, Australia, and the Americas, with particular expertise in the UK healthcare market and specialty medicines.
• Strategic Pharmaceutical Manufacturer Partnerships Partnership services for pharmaceutical manufacturers including pre-wholesale, hospital distribution, regulatory and import services, and exclusive distribution arrangements to support UK, European, and global market entry.
• International Logistics Hub Services European hub services for products manufactured outside the region, providing customs clearance, batch release, quality checks, and retention sample storage to support manufacturers entering European markets.
• Responsible Person Import (RPi) Services Importer of Record and Responsible Person Import services enabling pharmaceutical manufacturers to bring products into the UK market while remaining compliant with MHRA regulations.
• Aridol/Osmohale Exclusive Distribution Exclusive distribution of Aridol/Osmohale mannitol challenge test for asthma diagnosis and management in the UK and Ireland, manufactured by Pharmaxis Ltd; also serves as the European logistics hub for Pharmaxis's other distributors.
• ASCORBIC ACID PASCOE Exclusive Distribution Exclusive distribution of ASCORBIC ACID PASCOE 150mg/ml concentrate for solution for injection/infusion, manufactured by Pascoe Pharmazeutische Präparate GmbH, supplied to UK hospitals.

Quantifiable outcome

• Delivered newly approved cancer medicine to hospital in Switzerland within 24 hours of request
• +2 more outcomes

Named customers6 records

Segments4 records

Ideal customer profiles4 records

Technology focussed No

API detail

Has API

No

API docs

API detail

Core technology

AI maturity

App detail

Feature3 records

Partnerships

One partnership is on record.

• AscellaHealthcoreStrategic or Co-development Partner · 17 October 2024AscellaHealth acquired Chapper Healthcare in October 2024, deepening capabilities to serve international manufacturers and patients in 70+ countries. Chapper Healthcare serves as AscellaHealth's global pharmaceutical wholesaler, distributor, and commercialization service provider. The acquisition strengthens end-to-end specialty pharmacy solutions globally.

Scale indicators9 records

Recent moves12 records

Expansion highlights5 records

Direct peers

• Clinigen Group: UK-based specialty pharmaceutical services company focused on unlicensed medicine supply, named patient programmes, and clinical trials supply. The closest functional peer to Chapper's managed-access, clinical supply, and unlicensed-medicine business lines.
• Movianto (Owens & Minor): European specialty pharmaceutical logistics provider with temperature-controlled warehousing and GDP-compliant distribution. Operates in the same niche as Chapper's 3PL/cold-chain logistics offering across Europe.
• Trans-o-flex: Germany-based express delivery specialist for temperature-sensitive pharmaceuticals with active temperature control across Europe. Direct competitor for Chapper's cold-chain, time-critical medical logistics services in European markets.
• Alliance Healthcare (Walgreens Boots Alliance): UK-headquartered pharmaceutical wholesaler and distributor serving NHS hospitals, community pharmacies, and private healthcare providers. Directly comparable as a full-service pharma distribution competitor operating in the same UK/Ireland channels with extensive MHRA-licensed infrastructure.
• Phoenix Group: Germany-headquartered European pharmaceutical wholesale leader operating across 30+ European countries. Directly competes in EU hospital distribution, generic and specialty pharma supply, and operates EUROPACCESS-adjacent pharmacy networks.
• Uniphar Group: Ireland-based specialty pharmaceutical distribution and services group with hospital, wholesale, and clinical trial supply arms. Particularly comparable in its Irish and UK footprint and its specialisation in unlicensed and named-patient medicine supply.
• Specials Laboratory / PS Labs (Quantum Pharma): UK-based specials manufacturer and unlicensed medicine supplier with NHS and private hospital distribution. Directly comparable in the UK unlicensed-medicine supply and named-patient market that is core to Chapper's offering.

Broad incumbents

• McKesson: One of the largest global pharmaceutical wholesalers and distributors with extensive reach in Europe and North America. Overlaps with Chapper at the broad pharma distribution layer but operates at vastly greater scale and lacks Chapper's specialisation in unlicensed/cold-chain niche.
• Cencora (formerly AmerisourceBergen): Top-tier global pharmaceutical distributor with broad hospital and specialty distribution capabilities. Competitive overlap is at the broad-services level rather than Chapper's named-patient and unlicensed-niche specialism.

Others

• DHL Supply Chain – Life Sciences & Healthcare: Global contract logistics provider with dedicated life sciences and cold-chain pharma capabilities. Comparable as infrastructure partner/enabler rather than a direct channel competitor.

Market position

Strengths5 records

Weaknesses5 records

Competitive moat5 records

Key risks5 records

Key highlights7 records

Customer concentration

Compliance8 records

Revenue estimate

Valuation estimate

Number of profiles

Profiles9 records

Subsidiaries4 records

Funding overview

Funding rounds

Investors

Funding detail is available on the Subscription and Enterprise plan.Contact sales →

M&A

Investments

M&A and investment is available on the Subscription and Enterprise plan.Contact sales →

Frequently asked questions about Chapper Healthcare